Christopher E. Banas is a medical device industry veteran, with extensive leadership experience in cardiovascular company start-up, financing, management, research and development, scale up, regulatory approval and commercialization. Banas has held various executive management and engineering positions at prominent large companies such as StorageTek, W.L. Gore & Associates, Advanced Cardiovascular Systems/Guidant, Impra/C.R. Bard and Volcano Corporation. Banas has more than 35 years of product/process development experience resulting in the FDA and/or EU CE mark approval of over ten product families encompassing more than a hundred individual products, which were subsequently commercialized.
Banas co-founded five medical device companies, Advanced Bio Prosthetic Surfaces, Ltd. (ABPS), CardioSpectra, Inc, Aeon BioScience Inc., Bio2 Medical, Inc. and Prytime Medical. He is currently the President and CEO of Bio2 Medical the developer of the Angel® Catheter. The Angel® Catheter was approved by the FDA for the first ever prophylactic indication for the prevention of clinically significant pulmonary embolism (PE) in critically ill patients at high-risk for PE and contraindicated for anticoagulation and is now commercially available throughout the U.S.
Banas holds 72 issued US patents and currently has 74 published US applications in the fields of cardiovascular medicine, specifically, vascular surgery, interventional cardiology, nanotechnology and physical vapor deposition of Nitinol. Intellectual property portfolios developed by Banas have, in part, resulted in deals valued in excess of $300 million dollars, not including the value of future royalty income.
Banas also has extensive experience in life-science investing. Banas is a managing partner for Incyte Venture’s San Antonio-based Targeted Technology Fund I, and previously an advisor for the Dallas-based Scientific Health Development Fund. Banas has sat on a number of corporate boards, including serving as the Chairman of the Board for Resonetics, a New Hampshire-based excimer laser company supporting the medical device industry, and as a Director at Palmaz Scientific, a medical device company specializing in interventional cardiology products.